These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4363841)

  • 1. Hyperresponsiveness to lysine-vasopressin in Cushing's disease.
    Coslovsky R; Wajchenberg BL; Nogueira O
    Acta Endocrinol (Copenh); 1974 Jan; 75(1):125-32. PubMed ID: 4363841
    [No Abstract]   [Full Text] [Related]  

  • 2. Responses of plasma ACTH, GH, LH and 11-hydroxycorticosteroids to various stimuli in patients with Cushing's syndrome.
    Demura R; Demura H; Nunokawa T; Baba H; Miura K
    J Clin Endocrinol Metab; 1972 May; 34(5):852-9. PubMed ID: 4335044
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON THE CLINICAL ASPECTS, DIAGNOSIS AND THERAPY OF CUSHING'S SYNDROME].
    KOHLI P; MANN M; SIEGENTHALER W
    Med Klin; 1964 Apr; 59():599-605. PubMed ID: 14199972
    [No Abstract]   [Full Text] [Related]  

  • 4. Decreased melatonin concentration in Cushing's syndrome.
    Soszyński P; Stowińska-Srzednicka J; Kasperlik-Zatuska A; Zgliczyński S
    Horm Metab Res; 1989 Dec; 21(12):673-4. PubMed ID: 2559013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cushing's syndrome and the hypophysis. A re-evaluation of pituitary tumors and hyperadrenalism.
    Rovit RL; Berry R
    J Neurosurg; 1965 Sep; 23(3):270-95. PubMed ID: 4284589
    [No Abstract]   [Full Text] [Related]  

  • 6. Cushing's syndrome with hypertensive crisis and mixed adrenal cortical adenoma-pheochromocytoma (corticomedullary adenoma).
    Mathison DA; Waterhouse CA
    Am J Med; 1969 Oct; 47(4):635-41. PubMed ID: 5822980
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of adrenocorticotropic internal secretions in Cushing's syndrome].
    Silvestrini F; D'Alonzo R
    Schweiz Med Wochenschr; 1970 Oct; 100(40):1680-4. PubMed ID: 4335210
    [No Abstract]   [Full Text] [Related]  

  • 8. An unusual profile of endocrine study in a patient with pre-Cushing's syndrome.
    Kodama C; Nakada T; Sasagawa I; Ishigooka M; Yamaguchi T; Suzuki H
    Int Urol Nephrol; 1993; 25(6):517-24. PubMed ID: 8175270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathology of Cushing's syndrome].
    Saeger W; Mitschke H
    Dtsch Med Wochenschr; 1973 Jun; 98(25):1272-5. PubMed ID: 4351688
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocrotical adenoma by means of lysine-vasopressin.
    Bethge H; Bayer JM; Winkelmann W
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):47-59. PubMed ID: 4308289
    [No Abstract]   [Full Text] [Related]  

  • 11. Cushing's syndrome occurring with pituitary chromophobe tumors.
    MARKS V
    Acta Endocrinol (Copenh); 1959 Dec; 32():527-35. PubMed ID: 14421321
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adrenal Cushing's syndrome: clinico-pathologic review of 18 cases].
    Gómez-Huelgas R; Martín-Jiménez L; Valdivielso L; Collazos J; Renedo G; Ramos F; Arrieta F; Oliva H; Herrera Pombo JL
    Rev Clin Esp; 1984 Feb; 172(4):211-7. PubMed ID: 6739878
    [No Abstract]   [Full Text] [Related]  

  • 13. Cushing's disease with hyperprolactinaemia treated by transsphenoidal hypophysectomy.
    Cromer T; Clifton-Bligh P; Posen S; Rushworth R
    Med J Aust; 1980 Jun; 1(13):661-2. PubMed ID: 6252420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Negative responses to metopirone in Cushing's syndrome due to adrenal cortex adenoma or adenomatosis].
    de Gennes JL; Luton JP; Bricaire H
    Ann Endocrinol (Paris); 1971; 52(4):601-7. PubMed ID: 4333286
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of lysin-vasopressin in the differential diagnosis of cushing's syndrome.
    Croughs RJ
    Acta Endocrinol (Copenh); 1970 Dec; 65(4):595-607. PubMed ID: 5536687
    [No Abstract]   [Full Text] [Related]  

  • 16. Cushing's disease caused by pituitary chromophobe adenomas in two patients.
    CASSIDY CE
    Metabolism; 1960 Dec; 9():1139-51. PubMed ID: 13691345
    [No Abstract]   [Full Text] [Related]  

  • 17. Cushing's syndrome caused by a metyrapone responsive adrenocortical adenoma.
    Crystal RG; Rose LI; Jagger PI; Lauler DP
    J Clin Endocrinol Metab; 1970 Aug; 31(2):199-203. PubMed ID: 4317343
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of stimulation and suppression tests in the etiological diagnosis of Cushing's syndrome.
    Weiss ER; Rayyis SS; Nelson DH; Bethune JE
    Ann Intern Med; 1969 Nov; 71(5):941-9. PubMed ID: 4311765
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid mobilisation during infusion of a posterior pituitary extract and lysine-8-vasopressin. I.- Plasma NEFA, glucose and 17-hydroxycorticosteroids levels in normal subjects and in patients with pituitary disorders.
    Piotti LE; Locatelli GR; Carullo P
    Folia Endocrinol; 1967 Oct; 20(5):611-25. PubMed ID: 5631716
    [No Abstract]   [Full Text] [Related]  

  • 20. Cushing's syndrome with a paradoxical response to dexamethasone.
    French FS; Macfie JA; Baggett B; Williams TF; Van Wyk JJ
    Am J Med; 1969 Oct; 47(4):619-24. PubMed ID: 4309844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.